Essential role for the p110delta phosphoinositide 3-kinase in the allergic response. (Record no. 15186501)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02165 a2200661 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250514205354.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200411s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1476-4687 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1038/nature02991 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Ali, Khaled |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20041126 |
245 00 - TITLE STATEMENT | |
Title | Essential role for the p110delta phosphoinositide 3-kinase in the allergic response. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Nature |
Date of publication, distribution, etc. | Oct 2004 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1007-11 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anaphylaxis |
General subdivision | enzymology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Animals |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Adhesion |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Count |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Degranulation |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Movement |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Class I Phosphatidylinositol 3-Kinases |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cytokines |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dermis |
General subdivision | cytology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Genes, Essential |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hypersensitivity |
General subdivision | enzymology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Interleukin-3 |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Isoenzymes |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mast Cells |
General subdivision | cytology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice, Inbred BALB C |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice, Inbred C57BL |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Phosphatidylinositol 3-Kinases |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Phosphoinositide-3 Kinase Inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Receptors, IgE |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Second Messenger Systems |
General subdivision | physiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Stem Cell Factor |
General subdivision | pharmacology |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bilancio, Antonio |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Thomas, Matthew |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pearce, Wayne |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gilfillan, Alasdair M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tkaczyk, Christine |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kuehn, Nicolas |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gray, Alexander |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Giddings, June |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Peskett, Emma |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fox, Roy |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bruce, Ian |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Walker, Christoph |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sawyer, Carol |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Okkenhaug, Klaus |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Finan, Peter |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Vanhaesebroeck, Bart |
773 0# - HOST ITEM ENTRY | |
Title | Nature |
Related parts | vol. 431 |
-- | no. 7011 |
-- | p. 1007-11 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1038/nature02991">https://doi.org/10.1038/nature02991</a> |
Public note | Available from publisher's website |
No items available.